University Medical Center chleswig- Campus Kiel
Welcome,         Profile    Billing    Logout  
 18 Trials 
4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hijiya, Nobuko
T2017-002, NCT03817320 / 2019-001947-28: PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Active, not recruiting
1/2
31
US, RoW
Ixazomib, Vincristine, Dexamethasone, Asparaginase, Doxorubicin, Methotrexate (IT), Triple IT (Methotrexate, Hydrocortisone, Cytarabine), Leucovorin
Therapeutic Advances in Childhood Leukemia Consortium, Takeda, Children's Hospital Los Angeles
ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood
12/24
06/25
ASC4KIDS, NCT04925479 / 2021-001286-20: Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Recruiting
1/2
34
Europe, Japan, US, RoW
Asciminib Pediatric formulation group, ABL001, Asciminib Adult formulation group
Novartis Pharmaceuticals, Novartis Pharma AG
Myeloid Leukemia, Philadelphia Positive
06/26
11/31
NCT02879643: Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL

Recruiting
1
36
Canada, US, RoW
Marqibo
Therapeutic Advances in Childhood Leukemia Consortium, Spectrum Pharmaceuticals, Inc
ALL, Childhood, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Acute
08/21
12/22
Ramaswamy, Kavitha
REFUEL, NCT05460533: A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)

Recruiting
2
33
US
Tisagenlecleucel
Memorial Sloan Kettering Cancer Center, Novartis Pharmaceuticals
B-cell Acute Lymphoblastic Leukemia
07/26
07/26
Schrappe, M
No trials found
Kazi, Rafi R
No trials found

Download Options